RecruitingPhase 3NCT07727538
Rare condition
Familial lipoprotein lipase deficiency
3
studies recruiting now
as of 7 Sept 2026
31
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
27 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingEarly phase 1NCT07176923
CS-121 APOC3 Base Editing in FCS
RecruitingNot applicableNCT04227678
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Familial lipoprotein lipase deficiency studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Familial lipoprotein lipase deficiency study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Familial lipoprotein lipase deficiency
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (LPL).
Treatments being studied
3 approved treatments and 4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Alipogene Tiparvovec (Glybera)Approved: VolanesorsenApproved: Olezarsen
Phase 3Plozasiran
Phase 2/3Cyclosporine (Capimune)
Phase 2/3Mycophenolate Mofetil (Arzip)
Phase 2Prednisolone (Cortalone)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).